ArticleFrontiers in neurology
Prophylactic epidural blood patch for cerebrospinal fluid leakage after intrathecal drug delivery system implantation in patients with refractory cancer pain: a multi-center retrospective cohort study.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Current guidelines for postdural puncture cerebrospinal fluid (CSF) leakage advocate conservative management, extrapolated from general populations. Patients with refractory cancer pain (RCP) often have advanced disease, malnutrition, and hypoalbuminemia, which may compromise tissue repair and reduce the reliability of spontaneous dural closure. The role of prophylactic epidural blood patch (PEBP) in this high-risk subgroup is undefined. Methods: This multicenter retrospective cohort study enrolled RCP patients undergoing intrathecal drug delivery system (IDDS) implantation (Jan 2023-Aug 2025). Patients received either intraoperative PEBP (10-15 mL autologous blood) or conservative management (strict bed rest for 24-48 h, intravenous hydration 1,500-2,000 mL/day, oral caffeine). Propensity score matching (1:1) balanced recorded baseline and available procedural covariates. The primary outcome was moderate-to-severe postural headache syndrome (PHS). Results: After matching (78 patient pairs, Conclusion: In this retrospective cohort, intraoperative PEBP was associated with fewer early CSF leakage-related complications and shorter recovery after adjustment for recorded covariates. These findings support further prospective evaluation of PEBP in carefully selected patients. Prospective randomized controlled trials are warranted to validate these results. Causal inference, long-term safety, and patient-centered benefit require confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.